These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19828927)

  • 1. [Pharmacological and clinical properties of ECARD combination tablets LD & HD, fixed-dose combination of candesartan cilexetil and hydrochlorothiazide].
    Kusumoto K; Mori M; Tanokashira J; Totsuka N
    Nihon Yakurigaku Zasshi; 2009 Oct; 134(4):217-24. PubMed ID: 19828927
    [No Abstract]   [Full Text] [Related]  

  • 2. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
    Melian EB; Jarvis B
    Drugs; 2002; 62(5):787-816. PubMed ID: 11929332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interaction study with fixed high dose combinations of candesartan cilexetil and hydrochlorothiazide.
    Aberg JG; Olofsson B; Karlson BW
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):750-5. PubMed ID: 22122817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age.
    Schaefer F; van de Walle J; Zurowska A; Gimpel C; van Hoeck K; Drozdz D; Montini G; Bagdasorova IV; Sorof J; Sugg J; Teng R; Hainer JW;
    J Hypertens; 2010 May; 28(5):1083-90. PubMed ID: 20160654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological and clinical properties of AIMIX® combination tablets LD&HD, fixed-dose combination of irbesartan and amlodipine besilate].
    Mori M; Takahashi S
    Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):39-46. PubMed ID: 23842227
    [No Abstract]   [Full Text] [Related]  

  • 6. Candesartan plus hydrochlorothiazide: an overview of its use and efficacy.
    Mugellini A; Nieswandt V
    Expert Opin Pharmacother; 2012 Dec; 13(18):2699-709. PubMed ID: 23170938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with candesartan cilexetil plus hydrochlorothiazide in patients unresponsive to low-dose hydrochlorothiazide.
    Plouin PF
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S65-6. PubMed ID: 9331012
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-finding study of candesartan cilexetil plus hydrochlorothiazide in patients with mild to moderate hypertension.
    Philipp T; Letzel H; Arens HJ
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S67-8. PubMed ID: 9331013
    [No Abstract]   [Full Text] [Related]  

  • 9. Migraine treated using a prophylactic combination of candesartan and hydrochlorothiazide (ECARD Combination Tablets LD).
    Akiyama H; Hasegawa Y
    Pain Pract; 2013 Sep; 13(7):566-71. PubMed ID: 23126449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and bioequivalence study comparing a candesartan cilexetil/rosuvastatin calcium fixed-dose combination with the concomitant administration of candesartan cilexetil and rosuvastatin calcium in healthy Korean subjects
.
    Park DB; Jang K; Lee JW; Park CW; Lee BH; Kim MG; Jeon JY
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):286-294. PubMed ID: 28079517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ARB: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
    Mitsuyama S
    Nihon Rinsho; 2007 May; 65 Suppl 5():78-83. PubMed ID: 17571369
    [No Abstract]   [Full Text] [Related]  

  • 12. [Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with candesartan/HCTZ].
    Bramlage P; Schönrock E; Odoj P; Wolf WP; Funken C
    MMW Fortschr Med; 2008 Feb; 150(6):40. PubMed ID: 18323344
    [No Abstract]   [Full Text] [Related]  

  • 13. Candesartan cilexetil in cardiovascular disease.
    Ross A; Papademetriou V
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):829-35. PubMed ID: 15500428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic properties and bioequivalence of candesartan cilexetil in Korean healthy volunteers.
    Jeon JY; Im YJ; Kim Y; Han SM; Jo MJ; Shin DH; Yoo JS; Moon BK; Kim BK; Lee BH; Choi YH; Cho BS; Jang HY; Chae SW; Kim MG
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1296-9. PubMed ID: 23030309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of solid oral dosage form incorporating candesartan nanoparticles.
    Nekkanti V; Pillai R; Venkateshwarlu V; Harisudhan T
    Pharm Dev Technol; 2009; 14(3):290-8. PubMed ID: 19235553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension.
    Deeks ED
    Am J Cardiovasc Drugs; 2009; 9(6):411-8. PubMed ID: 19929039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
    MMW Fortschr Med; 2003 Apr; 145(15):62. PubMed ID: 15104271
    [No Abstract]   [Full Text] [Related]  

  • 19. [Successful high dosage fixed combination. 7 of 10 patients achieve target blood pressure].
    MMW Fortschr Med; 2006 Nov; 148(45):59. PubMed ID: 17615754
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observational study of blood pressure control and microalbuminuria in type 2 diabetics on Irbesartan or Irbesartan/HCTZ].
    Schmieder RE; Krekler M
    MMW Fortschr Med; 2005 Aug; 147(31-32):43. PubMed ID: 16128197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.